KILR™ Cytotoxicity Assays and Retroparticles
Enabling Cancer Immunotherapy: From Discovery to Combinations
Measure Target Cancer Cell Death in Co-Cultures
Cell-based Assays for Immunotherapy Drug Development
Identify Compounds that Rescue Disease Relevant Mutant Membrane Proteins